CLINICAL_TRIALS trial_result · 2026-07-30

Clinical Trial Results: A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain [Phase 2]

Phase 2 trial results for LY3556050 in diabetic peripheral neuropathic pain have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2026-07-30